GHRP-2 vs GHRP-6
Updated: April 25, 2026
| Feature | GHRP-2 | GHRP-6 |
|---|---|---|
| Class | GHRP | GHRP |
| Fridge profile | Standard decay profile | Standard decay profile |
| Freeze sensitivity | Do not freeze reconstituted | Do not freeze reconstituted |
| Workflow note | Requires disciplined handling | Requires disciplined handling |
Practical Selection Criteria
- Target endpoint and protocol objective
- Tolerance profile and timing constraints
- Ability to maintain strict storage consistency
Storage Guidance
Both compounds should be treated as handling-sensitive once reconstituted. Avoid freeze-thaw events and use clear date-based tracking.
Evidence Basis
- Freeze guidance — do not freeze reconstituted: Based on general protein aggregation principles during freeze-thaw. Hauptmann et al. — Freezing-induced protein aggregation and pH shift (PMID 32335158, Int J Pharm 2020); Mazur et al. — Freeze-thaw characterization (PMID 34059716, Sci Rep 2021). Note: GHRP-specific freeze assay data is not available in peer-reviewed literature; "do not freeze reconstituted" is a conservative model estimate based on general peptide stability principles.
- GHRP mechanism: Ghrelin-pathway GH secretagogues. Smith et al. — growth hormone secretagogue receptor family members and ligands (PMID 11322507); Proulx et al. — structure and receptor affinity work on GHRP-6 analogues (PMID 22712585); Cabrales et al. — pharmacokinetic study of GHRP-6 (PMID 23099431).
- Storage framework: ICH Q1A(R2) + ICH Q5C. Decay rates are [Model Estimates — PeptideClock].